Loading
Life sciences · Journal article
Journal of Innovative Optical Health Sciences · September 18, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Precise quantification of tissue oxygenation (pO 2 ) is important for understanding tumor progression and evaluating metabolic therapies. However, conventional intensity-based optical oxygen sensors suffer from severe signal fluctuations for in vivo measurements due to tissue scattering and excitation conditions. Here, we present a robust quantitative oxygen sensing platform by using ultra-bright phosphorescent semiconducting polymer dots (Pdots) and a custom-built time-gated phosphorescence lifetime imaging (PLIM) system. Polyfluorene serves as a light-harvesting unit that sensitizes oxygen-responsive metalloporphyrin moieties through intraparticle energy transfer, yielding bright oxygen-sensitive Pdots with a large excitation-emission separation. The PLIM system consists of an intensified scientific complementary metal-oxide-semiconductor (sCMOS) camera with an internal trigger for pulsed LED excitation. We demonstrated the longitudinal imaging of local microenvironmental pO 2 in a murine breast tumor model over an 8-day period. While intensity imaging suffers from signal degradation due to tumor growth and probe dilution, the PLIM system reliably captures a dynamic change in tumor oxygenation, with pO 2 increasing from a hypoxic level (<10 mmHg) on Day 1 to ~43 mmHg on Day 8. This trend likely reflects tumor vascular remodeling during early-stage growth. Our study provides a promising tool for tracking subcutaneous tissue metabolic dynamics and evaluating hypoxia-targeted cancer therapies.